![]() IRIDEX IRIDEX is an ophthalmic medical technology company focused on the development and commercialization of products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. | ||
Founding Date | Founding Date 1998 | Founding Date 1989 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations Brisbane, US HQ Sydney, AU Brussels, BE Lieusaint, FR München, DE Shibuya City, JP Pozuelo De Alarcón, ES see more | Locations Mountain View, US HQ Mannheim, DE |
Employees | Employees 43020% decrease | Employees 9316% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $212.4m (FY, 2023) | Revenue (est.) $52.7m (FY, 2026) |
Cost of goods | Cost of goods $170.9m (FY, 2023) | Cost of goods $33.4m (FY, 2026) |
Gross profit | Gross profit $41.5m (FY, 2023) | Gross profit $19.2m (FY, 2026) |
Net income | Net income ($162.8m) (FY, 2023) | Net income ($4.4m) (FY, 2026) |
Operating ⚠ | ||
Patents (US) | Patents (US) 26 (FY, 2020) | Patents (US) 62 (FY, 2022) |

IRIDEX is an ophthalmic medical technology company focused on the development and commercialization of products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases.
View company